Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis

Ads

You May Also Like

Correction new weekday: Oncology Venture: Kallelse till extra bolagsstämma

INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLINGNOTICE TO CONVENE EXTRAORDINARY GENERAL MEETINGKALLELSE TILL EXTRA BOLAGSSTÄMMA Der indkaldes ...

Corvus Announces Pricing of Initial Public Offering

BURLINGAME, Calif., March 22, 2016 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical ...